CSIMarket Company Name, Ticker, Competitors, else..
 
Cosmos Health Inc   (NASDAQ: COSM)
 
Price: $0.2428 $0.02 7.911%
Day's High: $0.257999986410141 Week Perf: 18.44 %
Day's Low: $ 0.23 30 Day Perf: 12.41 %
Volume (M): 5,281,967 52 Wk High: $ 1.32
Volume (M$): $ 0 52 Wk Avg: $0.48
Open: $0.23 52 Wk Low: $0.16



 Market Capitalization (Millions $) 15
 Shares Outstanding (Millions) 60
 Employees 163
 Revenues (TTM) (Millions $) 74
 Net Income (TTM) (Millions $) -24
 Cash Flow (TTM) (Millions $) 2
 Capital Exp. (TTM) (Millions $) 0

Business Description


Cosmos Health Inc is a healthcare technology company that focuses on revolutionizing the way people access and receive healthcare services. They utilize innovative technology and telemedicine platforms to provide convenient and accessible healthcare solutions to patients. The company aims to bridge the gap between patients and healthcare providers by offering virtual consultations, remote monitoring, and digital health solutions. Cosmos Health Inc is dedicated to improving healthcare outcomes and driving efficiency in the healthcare industry through their cutting-edge solutions.


   Company Address: 5 Agiou Georgiou Str Thessaloniki 55438
   Company Phone Number: 536-3102   Stock Exchange / Ticker: NASDAQ COSM


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
CLOV        0.97% 
UNH   -2.34%    
• View Complete Report
   



Product Service News

Cosmos Healths $2 Million Ethereum Bet Pioneering Blockchain Integration in Healthcare,

Published Tue, Oct 21 2025 6:02 PM UTC

Harnessing Blockchain: Cosmos Health s Strategic Investment in Ethereum In a bold move reflecting both financial acumen and visionary foresight, Cosmos Health Inc., a pioneering force in the global healthcare landscape, has further entrenched itself in the world of digital assets. On October 21, 2025, the company announced the acquisition of an additional $200,000 worth of E...
Product Service News

Cosmos Health Embarks on U.S. Nutraceuticals Journey with Ambitious Growth Targets,

Published Mon, Sep 22 2025 12:34 PM UTC

Cosmos Health Ventures into U.S. Nutraceuticals Market with Sky Premium Life Brand, Anticipates Robust Financial Growth London, UK - Cosmos Health, a burgeoning player in the global health and wellness industry, has officially commenced its operations in the United States, targeting the lucrative $164 billion nutraceuticals market with its flagship brand, Sky Premium Life. T...
Contract

Navigating the GCC Nutraceuticals Landscape Cosmos Healths Strategic Foray into Oman

Published Thu, Sep 11 2025 12:26 PM UTC

In an ambitious stride into an effervescent market, Cosmos Health Inc. (NASDAQ: COSM) has expanded its presence within the Gulf Cooperation Council s (GCC) burgeoning nutraceuticals sector, signing a pivotal distribution agreement with Scientific Pharmacy in Oman. This strategic partnership heralds the launch of the Sky Premium Life product line, aligning Cosmos Health with ...
Product Service News

Skys the Limit Cosmos Health Soars with Strong UAE Demand,

Published Wed, May 7 2025 9:23 PM UTC

The Sky s the Limit: Cosmos Health Gains Momentum with New UAE Order In a promising expansion of its footprint in the health and wellness sector, Cosmos Health Inc. has secured a substantial follow-up order from Pharmalink for 80,000 units of its Sky Premium Life products in the United Arab Emirates. This comes on the heels of an impressive initial order of 130,000 unit...
Product Service News

Cosmos Health Accelerates Growth with Facility Upgrades and Strategic Partnership for AMBITASOL Production

Published Thu, Apr 10 2025 10:10 AM UTC

In a strategic move aimed at bolstering its operational capabilities, Cosmos Health is making significant strides in both its manufacturing infrastructure and product development portfolio. The company has recently expanded its facility upgrade program at Cana Laboratories, a decision that underscores its commitment to enhancing operational efficiency and production quality....



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.20
Price to Sales (Expected) -
Price to Book 0.7
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.09
Working Capital Ratio 1.62
Leverage Ratio (MRQ) 1.97
Total Debt to Equity 0.83
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.66 $
Revenues (TTM) 1.23 $
Cash Flow (TTM) 0.03 $
Cash 0.03 $
Book Value 0.35 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 452,318
Net Income per Employee (TTM) -149,637
Receivable Turnover Ratio (TTM) 3.95
Inventory Turnover Ratio (TTM) 12.23
Asset Turnover Ratio (TTM) 1.2

Profitability Ratios Current
Gross Margin (MRQ) 7.96 %
Operating Margin (MRQ) -15.41 %
Net Margin (MRQ) -32.06 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Cosmos Health Inc's Segments





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.